The ICH E6(R3) draft guideline for Good Clinical Practice (GCP), the global standard for clinical trial conduct, is anticipated to be finalized in the fall of 2024. While this update has many clinical trial sponsors reeling, there is still time to prepare before the guideline is finalized.  

Don’t panic. The key is in early preparation. First, we must understand the downstream impacts of the guidelines on your clinical trials. In our Knowledge Hub webinar, “Preparing for GCP E6(R3) Impacts on Regulatory, Clinical, and Quality,” you’ll learn: 

• Overview of ICH GCP E6(R3) changes  

• Key considerations across regulatory, clinical, and quality  

• Insight into assessing your clinical trial(s) status   

• How to prepare now for downstream impacts to ensure guidance compliance 

Speakers: 

• Elizabeth Bodi, Principal Consultant, Organizational & Quality Solutions, Halloran 

• Laura Gilliam, Lead Consultant, Organizational & Quality Solutions, Halloran 

• Mamta Puri-Lechner, Senior Consultant, Regulatory Affairs, Halloran 

• Meaghan Powers, Associate Principal Consultant, Clinical Development and Operations, Halloran 

We look forward to sharing our insights and answering your pressing questions.